Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis: the authors respond.
Thamer
Mae
M
Medical Technology and Practice Patterns Institute, Bethesda, Maryland 20814, USA.
Zhang
Yi
Y
Kaufman
James
J
Cotter
Dennis
D
Hernán
Miguel A
MA
D003153:Community Health Services / Q000191:economics* / Q000379:methods; D004305:Dose-Response Relationship, Drug; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000191:economics*; D006397:Hematinics / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D010067:Ownership / Q000191:economics*; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000191:economics* / Q000379:methods
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa